Back to search results

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

Abroad (travel likely)RecruitingPHASE2

Conditions

Relapsed Hodgkin Lymphoma · Refractory Hodgkin Lymphoma · Relapsed Non-Hodgkin Lymphoma · Refractory Non-Hodgkin Lymphoma · B-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, United States

    Contact: Study coordinator (Kat Ton, RN) · katton@iu.edu · (317) 278-8506
    Contact: Principal Investigator (Rita Assi, MD)

  • Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Kat Ton) · katton@iu.edu · (317) 278-8506
    Ahmad Al-Hader (Sub-investigator)
Study leads

  • Rita Assi, MD

    Principal Investigator

    Indiana University

View source on ClinicalTrials.gov(opens in a new tab)